Safety and Effectiveness of Indacaterol in Chronic Obstructive Pulmonary Disease Patients in South Korea-Reference-Cited by-同舟云学术

Safety and Effectiveness of Indacaterol in Chronic Obstructive Pulmonary Disease Patients in South Korea

Published:2017 Issue:1 Volume:80 Page:52
ISSN:1738-3536
Container-title:Tuberculosis and Respiratory Diseases
language:en
Short-container-title:Tuberc Respir Dis

Author:

Yum Ho-Kee¹,Kim Hak-Ryul²,Chang Yoon Soo³,Shin Kyeong-Cheol⁴,Kim Song⁵,Oh Yeon-Mok⁶

Affiliation:

1. Department of Internal Medicine, Inje University Seoul Paik Hospital, Inje University College of Medicine, Seoul, Korea.

2. Department of Internal Medicine, Wonkwang University School of Medicine, Iksan, Korea.

3. Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.

4. Division of Pulmonology and Allergy, Department of Internal Medicine, Regional Center for Respiratory Disease, Yeungnam University College of Medicine, Daegu, Korea.

5. Novartis Korea Ltd., Seoul, Korea.

6. Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Funder

Novartis Korea Ltd.

Publisher

The Korean Academy of Tuberculosis and Respiratory Diseases

Subject

Infectious Diseases,Pulmonary and Respiratory Medicine

Link

https://synapse.koreamed.org/pdf/10.4046/trd.2017.80.1.52

Reference12 articles.

1. Gold Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease [Internet]. Gold Initiative for Chronic Obstructive Lung Disease. 2016. cited 2016 Jan 12. Available from: http://www.goldcopd.org

2. Prevalence of Chronic Obstructive Lung Disease in Korea Using Data from the Fifth Korea National Health and Nutrition Examination Survey

3. Turning a Molecule into a Medicine: the Development of Indacaterol as a Novel Once-Daily Bronchodilator Treatment for Patients with COPD

4. Indacaterol

5. Addressing unmet needs in the treatment of COPD

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamics of the splicing factor SRSF6 protein show metastable conformations with potentially druggable sites revealed by Markov state model;Chemical Physics Letters;2024-02

2. Small molecules modulating RNA splicing: a review of targets and future perspectives;RSC Medicinal Chemistry;2024

3. Targeting Splicing Factor SRSF6 for Cancer Therapy;Frontiers in Cell and Developmental Biology;2021-11-30

4. Real-world Safety and Efficacy of Indacaterol Maleate in Patients with Chronic Obstructive Pulmonary Disease: Evidence from the Long-term Post-marketing Surveillance in Japan;Internal Medicine;2021-08-01

5. Fixed-Dose Combinations of Long-Acting Bronchodilators for the Management of COPD: Global and Asian Perspectives;Advances in Therapy;2019-02-11